(R)-Baclofen hydrochloride is a selective GABAB receptor agonist used to suppress audiogenic seizures in Fmr1-knockout mice on a seizure-resistant C57BL/6 background, with an effective dose of 1 mg/kg; it significantly reduces seizure incidence upon acute intraperitoneal administration, with a minimum effective dose (MED) of 1.5 mg/kg.